Exclusion Criteria:~* History or presence of brain MRI scans indicative of any other significant abnormality~*
Alcohol or drug dependence currently or within the past 1 year~* Presence of pacemakers, aneurysm clips,
artificial heart valves, ear implants, or foreign metal objects in the eyes, skin or body which would preclude
MRI scan.~* History or presence of clinically significant cardiovascular disease, hepatic/renal disorders,
infectious disease or immune disorder, or metabolic/endocrine disorders~* Anticoagulants except low dose (â‰¤ 325
mg) aspirin.~* Have been exposed to a monoclonal antibody targeting beta amyloid peptide within the past six
months.~* History of cancer within the last 5 years, except basal cell carcinoma, non-squamous skin carcinoma,
prostate cancer or carcinoma in situ with no significant progression over the past 2 years.~* Positive urine or
serum pregnancy test or plans or desires to become pregnant during the course of the trial.~* Subjects unable
to complete all study related testing, including implanted metal that cannot be removed for MRI scanning,
required anticoagulation and pregnancy.
